Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2000
10/25/2000CN1271283A Endothelin antogonist and a renin-angiotensin system inhibitor as a combined preparation
10/25/2000CN1271277A Biodegradable macromers fro the controlled release of biologically active substances
10/25/2000CN1271275A Small particle liposome aerosols for delivery of atni-cancer drugs
10/25/2000CN1270960A Process for preparing growth hormone cinogenic agent
10/25/2000CN1270837A Beri-beri treating medicine
10/25/2000CN1057775C Anti-thrombus active peptide and preparation method thereof
10/25/2000CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders
10/25/2000CN1057670C Prolonged release preparation and polymers thereof
10/24/2000US6137029 Chimeric gene formed by fusion of the promoter of pepck (p-enolpyruvate carboxyquinase) to the structural gene of human insulin; allows physiologically regulated production of human insulin, in a tissue different from the pancreas
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136955 Mammalian polypeptide associated with spindle and centromers; for the diagnosis, prevention and treatment of cell proliferation defects
10/24/2000US6136953 Human antiproliferative polypeptide for the detection of vascular injuries
10/24/2000US6136952 Human jagged polypeptide, encoding nucleic acids and methods of use
10/24/2000US6136834 Tetrazole compounds and pharmaceutical agents containing such derivative
10/24/2000US6136804 Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
10/24/2000US6136798 Compounds inhibiting the association of the PDGF receptor and phosphatidylinositol 3-kinase and their use
10/24/2000US6136796 Drugs for antiischemic agents, strokes, antiepileptic agents and antiasthma agents
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136788 Pharmaceutical preparation for the therapy of immune deficiency conditions
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136786 Analgesics produced by opiates from omega-conopeptides
10/24/2000US6136785 Protection from loss of sensory hair cells in the inner ear by administration of insulin-like growth factor and platelet derived growth factor
10/24/2000US6136784 Amylin agonist pharmaceutical compositions containing insulin
10/24/2000US6136783 Antifungal compositions
10/24/2000US6136782 Multimeric antithrombotic agents
10/24/2000US6136781 LH-RH receptor antagonists
10/24/2000US6136780 Administering naltrexone or naloxone to treat gastrointestinal cancer, particularly colon or pancreatic cancer
10/24/2000US6136605 Glutathione S-transferase isoforms
10/24/2000US6136604 Oligonucleotides which target preferential nucleotide sequences for the suppression on expression of human enzyme; for treatment of skin disorders; anticarcinogenic agents; antiinflammatory agents
10/24/2000US6136603 Oligonucleotides which target the untranslated region of a cytokine receptor gene; for treatment of eosinophil defects such as asthma, rhinitis and dermatitis; wound healing agents; antiinflammatory agents; anticarcinogenic agents
10/24/2000US6136602 Nucleotide sequences which can hybridize to preferential target nucleic acids; for the suppression of the expression of genes associated with antibiotic resistance and the prevention of bacterial infections
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136586 Methods for the selective modification of viral nucleic acids
10/24/2000US6136574 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/24/2000US6136572 Recombinant KAT enzyme and process for its preparation
10/24/2000US6136565 Methods of reducing the levels of protoporphyrin IX in recombinant hemoglobin preparations
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136562 Synthetic dna which encodes a peptide having a defined amino acid sequence; for recombinant production of the peptide for use in cattle; veterinary medicine
10/24/2000US6136560 Amidotransferase, ratB, of streptococcus pneumoniae
10/24/2000US6136556 TCTS response regulator
10/24/2000US6136548 Mutating one or more amino acids of tissue plasminogen activator, then measuring binding of mutant to beta amyloid peptide and to fibrin; improved mutant binds fibrin but does not bind beta-amyloid peptide; for alzheimer's patients
10/24/2000US6136539 Compositions and methods for the inhibition of MUC-5 mucin gene expression
10/24/2000US6136367 Composition and its use as a food supplement or for lowering lipids in serum
10/24/2000US6136357 Anhydrous; cyclosporin; monoglycerides, diglycerides, and/or triglycerides of natural fatty acids; natural fatty acids and/or their alkaline salts; a substance containing 3-sn-phosphatidyl choline and/or phosphatidyl ethanolamine
10/24/2000US6136346 Spray drying an aqueous mixture of an excipient, a dispersibility-enhancing, water soluble polypeptide and drug to obtain an aerosolizable powder for inhalation therapy having increased dispersibility due to the polypeptide
10/24/2000US6136319 Method of treating viral diseases in animals
10/24/2000US6136315 Compositions and methods using complexes of heat shock protein 70 and antigenic molecules for the treatment and prevention of neoplastic diseases
10/24/2000US6136314 Histone fusion protein
10/24/2000US6136313 Processes and intermediates for synthetic antibody derivatives
10/24/2000US6136312 Method for producing an IgM preparation for intravenous application
10/24/2000US6136310 Recombinant anti-CD4 antibodies for human therapy
10/24/2000US6136309 Antibodies against the interferon (IFN) α/β receptor (IFNAR2) that preferentially block the activity of IFN-α
10/24/2000CA2221148C Muscle trophic factor
10/24/2000CA2220873C Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
10/24/2000CA2139664C Covalent polar lipid-peptide conjugates for biological targeting
10/24/2000CA2047702C Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression
10/24/2000CA1341124C Genetic engineering process for the preparation of hirudins, and means for carrying out this process
10/21/2000CA2268379A1 Inhibitor ligands directed against a receptor of vascular endothelial growth factor or against its coding sequence, as anti-angiogenics
10/20/2000CA2306355A1 Methods and compositions for treating human cells
10/19/2000WO2000062067A1 Novel transduction molecules and methods for using same
10/19/2000WO2000062063A1 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061810A1 Antisense oligonucleotides comprising universal and/or degenerate bases
10/19/2000WO2000061804A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000WO2000061793A2 Novel method for identifying antibacterial compounds
10/19/2000WO2000061789A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000WO2000061786A2 Antisense modulation of pdk-1 expression
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061778A1 Staphylococcus aureus mvaa
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061766A2 Telomerase-specific cancer vaccine
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061761A2 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
10/19/2000WO2000061760A1 Piromyces equi carbohydrate binding domains
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061752A2 Modified complement system regulators
10/19/2000WO2000061749A1 Cellular protein p60 that interacts with herpesvirus regulatory proteins
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061747A2 Clasp-2 transmembrane proteins
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061744A1 Novel fetal genes
10/19/2000WO2000061743A1 Apoptosis-associated gene
10/19/2000WO2000061742A2 Treatment of cardiac power failure using s100 proteins
10/19/2000WO2000061741A1 Pcr-based cloning method
10/19/2000WO2000061738A2 Differential regulation of gene expression in oncogenic transformation
10/19/2000WO2000061729A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
10/19/2000WO2000061633A1 Method for purifying blood coagulation factor viii and blood coagulation factor viii/von willebrand factor complex
10/19/2000WO2000061632A1 Interaction of mhc class ii proteins with members of the pcna family of proteins
10/19/2000WO2000061631A1 Modified pentapeptide antagonists of the atrial natriuretic peptide clearance receptor
10/19/2000WO2000061629A1 49 human secreted proteins
10/19/2000WO2000061628A1 49 human secreted proteins
10/19/2000WO2000061627A1 49 human secreted proteins
10/19/2000WO2000061625A1 48 human secreted proteins
10/19/2000WO2000061624A1 48 human secreted proteins
10/19/2000WO2000061623A1 62 human secreted proteins
1 ... 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 ... 3163